Focus: Faes Farma is a Spanish-headquartered biotech company with 501-1,000 employees specializing in small molecule development across dermatology and allergy therapeutics. The company operates as a publicly-traded entity with a focused pipeline centered on dermatological and allergic condition treatments.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Faes Farma to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Multi-indication Phase 2/3 platform with 10+ active programs representing the company's core strategic franchise and primary development engine.
Help build intelligence for Faes Farma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Faes Farma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Phase 3 program in dermatology demonstrating portfolio breadth beyond allergy indications.
Phase 3 GI inflammatory program expanding therapeutic area footprint beyond dermatology.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moRecent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications